Therapeutic effects of estradiol benzoate on development of collagen‐induced arthritis (CIA) in the Lewis rat are mediated via suppression of the humoral response against denatured collagen type II (CII)

SUMMARY The effects of estradiol benzoate (EB) on the development of anti‐CII antibodies and their pathogenic potential were studied during the progress of established CIA in the rat. CIA was induced in mature female Lewis rats by two subcutaneous inoculations containing bovine native CII (BCIIn), emulsified in Freund's incomplete adjuvant. Clinical arthritis fully developed by day 18 and then EB (1 mg/kg body wt per day, diluted in corn oil (CO)) was administered intramuscularly every second day thereafter. Antibodies binding four different CIIs (bovine or rat, either native or heat‐denatured) were detected in sera and joint tissue extracts by means of solid‐phase ELISA. Pharmacological doses of EB (>0±2 mg/kg body wt per day) caused significant remission of established CIA 5‐7 days after treatment, and selectively suppressed the production of antibodies specific for denatured CII. To evaluate the arthritogenic potential of circulating anti‐CIId IgG, transfer experiments were performed. IgG anti‐CIIn, purified from EB‐treated CIA rats, was not arthritogenic, whereas IgG anti‐denatured (CIId), purified from CO‐treated CIA rats, caused severe passive arthritis. Furthermore, pretreatment with rat CIId protected against subsequent induction of CIA, and this protection was associated with suppressed antibody production against CIId. Collectively, our results indicate that antibodies specific for CIId are involved in the pathogenesis of CIA, and that oestrogen‐related remission of clinical arthritis may be caused by a selective suppression of antibodies produced against degraded denatured CII.